India · Delayed Price · Currency is INR Transgene Biotek Statistics
Total Valuation
BOM:526139 has a market cap or net worth of INR 233.37 million. The enterprise value is 404.13 million.
| Market Cap | 233.37M |
| Enterprise Value | 404.13M |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:526139 has 75.77 million shares outstanding.
| Current Share Class | 75.77M |
| Shares Outstanding | 75.77M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 33.21% |
| Owned by Institutions (%) | 8.28% |
| Float | 50.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 110.50 |
| PB Ratio | 2.79 |
| P/TBV Ratio | 12.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 191.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.08, with a Debt / Equity ratio of 2.05.
| Current Ratio | 0.08 |
| Quick Ratio | 0.01 |
| Debt / Equity | 2.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.70 |
Financial Efficiency
Return on equity (ROE) is -17.96% and return on invested capital (ROIC) is -2.91%.
| Return on Equity (ROE) | -17.96% |
| Return on Assets (ROA) | -0.32% |
| Return on Invested Capital (ROIC) | -2.91% |
| Return on Capital Employed (ROCE) | -0.57% |
| Weighted Average Cost of Capital (WACC) | 7.73% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.65% in the last 52 weeks. The beta is 1.01, so BOM:526139's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | -37.65% |
| 50-Day Moving Average | 3.07 |
| 200-Day Moving Average | 3.07 |
| Relative Strength Index (RSI) | 51.52 |
| Average Volume (20 Days) | 33,537 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:526139 had revenue of INR 2.11 million and -16.53 million in losses. Loss per share was -0.22.
| Revenue | 2.11M |
| Gross Profit | 2.11M |
| Operating Income | -7.43M |
| Pretax Income | -16.53M |
| Net Income | -16.53M |
| EBITDA | -5.44M |
| EBIT | -7.43M |
| Loss Per Share | -0.22 |
Balance Sheet
The company has 608,000 in cash and 171.37 million in debt, with a net cash position of -170.76 million or -2.25 per share.
| Cash & Cash Equivalents | 608,000 |
| Total Debt | 171.37M |
| Net Cash | -170.76M |
| Net Cash Per Share | -2.25 |
| Equity (Book Value) | 83.77M |
| Book Value Per Share | 1.11 |
| Working Capital | -122.29M |
Cash Flow
| Operating Cash Flow | -113,000 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.99M |
| Net Borrowing | 6.98M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -351.61% |
| Pretax Margin | -782.62% |
| Profit Margin | n/a |
| EBITDA Margin | -257.34% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BOM:526139 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -7.08% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |